Table 4 |
|||
|
Multivariate analyses for DFS. |
|||
|
Variables |
p value |
relative risk |
95% CI |
|
|
|||
|
Tumor size (cm): |
|||
|
2.1 – 5.0 (vs. – 2.0) |
0.8905 |
1.06 |
0.49–2.26 |
|
5.1 – (vs. – 2.0) |
0.2467 |
1.72 |
0.69–4.29 |
|
Lymph node metastasis: |
|||
|
present (vs. absent) |
<0.0001 |
6.14 |
3.30–11.4 |
|
Nuclear grade: |
|||
|
III (vs. I or II) |
0.2791 |
1.39 |
0.77–2.52 |
|
Estrogen receptor: |
|||
|
negative (vs. positive) |
0.8502 |
1.06 |
0.59–1.89 |
|
p27 protein expression: |
|||
|
decreased (vs. normal) |
0.8976 |
1.04 |
0.58–1.85 |
|
p53 protein expression: |
|||
|
positive (vs. negative) |
0.3988 |
1.29 |
0.71–2.34 |
|
MIB-1 counts: |
|||
|
10%≤ (vs.<10%) |
0.0029 |
2.29 |
1.33–3.96 |
|
Bcl-2 protein: |
|||
|
decreased (vs. normal) |
0.4037 |
1.34 |
0.68–2.64 |
|
|
|||
|
Tsutsui et al. BMC Cancer 2006 6:187 doi:10.1186/1471-2407-6-187 |
|||